Milestone Pharmaceuticals Inc.
Organization details
- Legal name
- Milestone Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Quebec, Canada
- Headquarters city
- Montreal
- Headquarters country
- Canada
- Fiscal year end
- December
- Ticker symbol
- MIST
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001408443
Board of directors
-
Andrew Saik · DirectorSince 2024
-
Debra K. Liebert · DirectorSince 2023
-
Joseph C. Papa · DirectorSince 2024
-
Joseph Oliveto · Director · President and CEOSince 2023
-
Lisa M. Giles · DirectorSince 2023
-
Michael John Tomsicek · DirectorSince 2023
-
Richard C. Pasternak · DirectorSince 2023
-
Robert James Wills · DirectorSince 2023
-
Seth H. Z. Fischer · DirectorSince 2023
-
Stuart Duty · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.7%
-
85.9%
-
87.6%
-
88.1%
-
88.4%
-
88.5%
-
88.5%
-
88.5%
Board connections
5 of this board's directors also sit on 8 other boards. 7 are in the same sector.
-
Achieve Life Sciences Inc. Same sectorvia Stuart Duty
-
Acrivon Therapeutics Inc. Same sectorvia Michael John Tomsicek
-
Alpha Cognition Inc. Same sectorvia Robert James Wills
-
Candel Therapeutics Inc. Same sectorvia Joseph C. Papa
-
Emergent BioSolutions Inc. Same sectorvia Joseph C. Papa
- via Stuart Duty
-
Foghorn Therapeutics Inc. Same sectorvia Stuart Duty
-
HCW Biologics Inc. Same sectorvia Lisa M. Giles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,176,157
- 13 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −36,500 | $2.26 | $82,490 |
| Jan 26, 2026 | Bharucha David Officer (Chief Medical Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Muller Lorenz Officer (Chief Commercial Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Hasija Amit Officer (CFO & EVP of Corp. Development) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Option exercise | +66,600 | — | — |
| Jan 26, 2026 | Bharucha David Officer (Chief Medical Officer) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Muller Lorenz Officer (Chief Commercial Officer) | Open-market sale | −11,180 | $1.93 | $21,577 |
| Jan 26, 2026 | Hasija Amit Officer (CFO & EVP of Corp. Development) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −34,523 | $1.93 | $66,629 |
| Jan 8, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −43,000 | $2.25 | $96,750 |
| Jan 7, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −500 | $2.25 | $1,125 |
| Dec 15, 2025 | Bharucha David Officer (Chief Medical Officer) | Open-market sale | −58,007 | $2.32 | $134,576 |
| Dec 15, 2025 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Open-market sale | −58,007 | $2.32 | $134,576 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Milestone Pharmaceuticals Inc.
Who is the CEO of Milestone Pharmaceuticals Inc.?
Joseph Oliveto is Milestone Pharmaceuticals Inc.'s President and CEO.
How many directors are on Milestone Pharmaceuticals Inc.'s board?
Milestone Pharmaceuticals Inc.'s board has 10 directors: Andrew Saik, Debra K. Liebert, Joseph C. Papa, Joseph Oliveto, Lisa M. Giles, Michael John Tomsicek, Richard C. Pasternak, Robert James Wills, Seth H. Z. Fischer and Stuart Duty.
Are Milestone Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Milestone Pharmaceuticals Inc. insiders made no open-market purchases and sold $1.2 million of shares in 13 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="milestone-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.